MODIFIED STANDARD BRITE TIP SHEATH-INTRODUTTORE Italien - Italienisch - Ministero della Salute

modified standard brite tip sheath-introduttore

cordis corporation - introduttori valvolati per apparato cardiocircolatorio

MODIFIED ADAMS CLASP Italien - Italienisch - Ministero della Salute

modified adams clasp

tp orthodontics inc. - fili per ortodonzia

MODIFIED MEYERDING (RIGHT) Italien - Italienisch - Ministero della Salute

modified meyerding (right)

omni-tract surgical, a division of minnesota scientific, inc - divaricatori e retrattori per chirurgia generale - altri

MODIFIED MEYERDING (LEFT) Italien - Italienisch - Ministero della Salute

modified meyerding (left)

omni-tract surgical, a division of minnesota scientific, inc - divaricatori e retrattori per chirurgia generale - altri

MODIFIED HAM'S F-10 BASAL MEDIUM Italien - Italienisch - Ministero della Salute

modified ham's f-10 basal medium

irvine scientific - dispositivi per procreazione assistita - altri

Shu Jing Hou Xue Tang Modified Italien - Italienisch - Ministero della Salute

shu jing hou xue tang modified

qiu tian srl -

Comirnaty Europäische Union - Italienisch - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccini - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

Natrixam 1.5mg/5mg compresse a rilascio modificato Schweiz - Italienisch - Swissmedic (Swiss Agency for Therapeutic Products)

natrixam 1.5mg/5mg compresse a rilascio modificato

servier (suisse) sa - indapamidum, amlodipinum - compresse a rilascio modificato - indapamidum 1.5 mg, hypromellosum, lactosum monohydricum 104.5 mg, magnesii stearas, povidonum k 30, silica colloidalis anhydrica, amlodipinum 5 mg ut amlodipini besilas 6.935 mg, calcii hydrogenophosphas dihydricus, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.69 mg, magnesii stearas, amylum pregelificatum, silica colloidalis anhydrica, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, pro compresso obducto. - ipertensione - synthetika

Natrixam 1.5mg/10mg compresse a rilascio modificato Schweiz - Italienisch - Swissmedic (Swiss Agency for Therapeutic Products)

natrixam 1.5mg/10mg compresse a rilascio modificato

servier (suisse) sa - indapamidum, amlodipinum - compresse a rilascio modificato - indapamidum 1.5 mg, hypromellosum, lactosum monohydricum 104.5 mg, magnesii stearas, povidonum k 30, silica colloidalis anhydrica, amlodipinum 10 mg ut amlodipini besilas 13.87 mg, calcii hydrogenophosphas dihydricus, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.69 mg, magnesii stearas, amylum pregelificatum, silica colloidalis anhydrica, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, e 172, pro compresso obducto. - ipertensione - synthetika

Gliclazid MR Servier 30mg compresse a rilascio modificato Schweiz - Italienisch - Swissmedic (Swiss Agency for Therapeutic Products)

gliclazid mr servier 30mg compresse a rilascio modificato

servier (suisse) sa - gliclazidum - compresse a rilascio modificato - gliclazidum 30 mg, excipiens pro compresso. - il diabete orale - synthetika